Skip to main content

Table 3 Results of mycological cultures of samples from the AmarCAND2 patients, according to their status at SAT initiation: invasive candidiasis either proven, or suspected

From: Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study

  SAT for proven invasive candidiasis
N = 291
SAT for suspected invasive candidiasis
N = 544
Overall population
N = 835
Patients with at least an isolate identified, i.e., proven IC 291 (100) 112 (20.6) 403 (48.3 %)
Number of identified isolates 325 128 453
C. albicans 206 (63.4) 90 (70.3) 296 (65.3)
C. glabrata 54 (16.6) 18 (14.0) 72 (15.9)
C. parapsilosis 19 (5.8) 2 (1.6) 21 (4.6)
C. tropicalis 14 (4.3) 6 (4.7) 20 (4.4)
C. krusei 10 3 13
C. lusitaniae 9 1 10
C. kefyr 6 2 8
C. guilliermondii 3 1 4
C. dubliniensis 2 0 2
C. norvengiensis 1 1 2
C. pulcherina 1 0 1
Other 0 4 4
  1. The results are given as n (%)
  2. SAT systemic antifungal therapy, IC invasive candidiasis